Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan for acute migraine in children and adolescents
NL-OMON34773Phase 3Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Rizatriptan with Placebo (2 arms). Primary endpoints: Pain freedom at 2 hours in adolescents and Safety and tolerability in adolescents. Started Apr 2010; status: active, not recruiting.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON34773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34773.